These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8233725)

  • 1. Complement activation in newborn infants with early onset infection.
    Zilow G; Zilow EP; Burger R; Linderkamp O
    Pediatr Res; 1993 Aug; 34(2):199-203. PubMed ID: 8233725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative pathway activation of the complement system in preterm infants with early onset infection.
    Zilow EP; Hauck W; Linderkamp O; Zilow G
    Pediatr Res; 1997 Mar; 41(3):334-9. PubMed ID: 9078531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement activation in patients with isolated antiphospholipid antibodies or primary antiphospholipid syndrome.
    Breen KA; Seed P; Parmar K; Moore GW; Stuart-Smith SE; Hunt BJ
    Thromb Haemost; 2012 Mar; 107(3):423-9. PubMed ID: 22234447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel C3 mutation causing increased formation of the C3 convertase in familial atypical hemolytic uremic syndrome.
    Sartz L; Olin AI; Kristoffersson AC; Ståhl AL; Johansson ME; Westman K; Fremeaux-Bacchi V; Nilsson-Ekdahl K; Karpman D
    J Immunol; 2012 Feb; 188(4):2030-7. PubMed ID: 22250080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the complement system in normal pregnancy and preeclampsia.
    Derzsy Z; Prohászka Z; Rigó J; Füst G; Molvarec A
    Mol Immunol; 2010 Apr; 47(7-8):1500-6. PubMed ID: 20181396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of the anaphylatoxin C3a in the presence of C3 by a novel sandwich ELISA using monoclonal antibody to a C3a neoepitope.
    Zilow G; Naser W; Rutz R; Burger R
    J Immunol Methods; 1989 Jul; 121(2):261-8. PubMed ID: 2503562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Activation of complement and serial changes of anaphylatoxin (C3a, C5a) in patients for open-heart surgery using a membrane oxygenator].
    Mitsuhata H; Enzan K; Hasegawa J; Matumoto S; Matsumoto J; Kurosawa S
    Masui; 1992 Feb; 41(2):194-9. PubMed ID: 1552659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement profile in neonates of different gestational ages.
    Grumach AS; Ceccon ME; Rutz R; Fertig A; Kirschfink M
    Scand J Immunol; 2014 Apr; 79(4):276-81. PubMed ID: 24460650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood activation during neonatal extracorporeal life support.
    Plötz FB; van Oeveren W; Bartlett RH; Wildevuur CR
    J Thorac Cardiovasc Surg; 1993 May; 105(5):823-32. PubMed ID: 7683735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement activation products in liquid stored plasma and C3a kinetics after transfusion of autologous plasma.
    Norda R; Schött U; Berséus O; Akerblom O; Nilsson B; Ekdahl KN; Stegmayr BG; Knutson F
    Vox Sang; 2012 Feb; 102(2):125-33. PubMed ID: 21770955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SC5b-9 is the most sensitive marker in assessing disease activity in Brazilian SLE patients.
    Chiu YY; Nisihara RM; Würzner R; Kirschfink M; de Messias-Reason IJ
    J Investig Allergol Clin Immunol; 1998; 8(4):239-44. PubMed ID: 9777539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The analysis of the complement activation product SC5 b-9 is applicable in neonates in spite of their profound C9 deficiency.
    Høgåsen AK; Overlie I; Hansen TW; Abrahamsen TG; Finne PH; Høgåsen K
    J Perinat Med; 2000; 28(1):39-48. PubMed ID: 10765513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement activation and group B streptococcal infection in the newborn: similarities to endotoxin shock.
    Fenton LJ; Strunk RC
    Pediatrics; 1977 Dec; 60(6):901-7. PubMed ID: 341069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The C terminus of the anaphylatoxin C3a generated upon complement activation represents a neoantigenic determinant with diagnostic potential.
    Burger R; Zilow G; Bader A; Friedlein A; Naser W
    J Immunol; 1988 Jul; 141(2):553-8. PubMed ID: 2454995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective activation of the third component of complement in the sera of newborn infants.
    Winkelstein JA; Kurlandsky LE; Swift AJ
    Pediatr Res; 1979 Oct; 13(10):1093-6. PubMed ID: 388331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistently circulating C3 nephritic factor (C3 NeF)-stabilized alternative pathway C3 convertase (C3 CoF) in serum of an 11-year-old girl with meningococcal septicemia--simultaneous occurrence with free C3 NeF.
    Wahn V; Müller W; Rieger C; Rother U
    Pediatr Res; 1987 Aug; 22(2):123-9. PubMed ID: 3658535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activation and endotoxin in sepsis.
    Padalino P; Gardinali M; Pallavicini J; Chiara O; Bisiani G; Nespoli A
    Prog Clin Biol Res; 1989; 308():277-82. PubMed ID: 2780700
    [No Abstract]   [Full Text] [Related]  

  • 18. Generation of anaphylatoxin C3a in plasma and bronchoalveolar lavage fluid in trauma patients at risk for the adult respiratory distress syndrome.
    Zilow G; Joka T; Obertacke U; Rother U; Kirschfink M
    Crit Care Med; 1992 Apr; 20(4):468-73. PubMed ID: 1559358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of exercise on complement activity.
    Smith JK; Chi DS; Krish G; Reynolds S; Cambron G
    Ann Allergy; 1990 Oct; 65(4):304-10. PubMed ID: 2221489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated plasma levels of C3a complement compound in the exudative form of age-related macular degeneration.
    Machalińska A; Dziedziejko V; Mozolewska-Piotrowska K; Karczewicz D; Wiszniewska B; Machaliński B
    Ophthalmic Res; 2009; 42(1):54-9. PubMed ID: 19478542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.